9th Congress of the European Academy of Paediatric Societies
October 7-11 2022, Barcelona and online
Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge model
In this human infection challenge pilot study, adults aged 18–55 years and 60–75 years were assessed for enrolment using protocol-defined inclusion and exclusion criteria.
World Influenza Conference
September 17-18 2022, Shenzen China - Virtual
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above.
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals.
8th International Influenza Meeting
September 2-4 2022, Munster
News
Policy & Recommendations
WHO announces flu strain selection
Full announcement by the WHO.
News
Standpoints
Partner Organisations
What are European countries doing to protect populations this Flu Season?
Steering group on Influenza Vaccination signs open letter
Agenda
Partner Organisations
News
World Vaccine Congress Europe 2022
October 11-14 2022, Barcelona
ESWI Webinars 2021 conclusions and recommendations
In 2021 ESWI held 5 webinars entitled: Preparing for COVID-19, RSV Disease and Influenza concomitant outbreaks.
Using correlates to accelerate vaccinology
Correlates and surrogates of desired outcomes are valuable but have limitations
